Keywords: final, phase, ii, data, biomira, theratope, canada

Final Phase II Data For Biomira's Theratope

Article | 18 November 1996

- Final Phase II data with Biomira of Canada's vaccine Theratope (Stn-KLH), for patients with metastatic or recurrent breast cancer, show ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in